Press Release | April 10, 2019
BERKELEY, CA – April 10, 2019
Actym Therapeutics announced that Dr. Christopher Thanos, President, CEO, and Cofounder, has been invited to speak at the 15th annual PEGS Conference in Boston, MA. Dr. Thanos’ presentation, “A Novel Systemically Delivered STING Pathway Agonist Therapy Demonstrates Robust Anti-Tumor Efficacy in Multiple Murine Cancer Models” will begin at 2:40 PM, EST. Dr. Thanos is also Chairperson of the all-day session at PEGS entitled, “Latest Developments in Agonist Immunotherapy – Stepping on the Gas”. The Conference will take place at the Seaport World Trade Center, Waterfront Rooms 1&2.
Actym Therapeutics, Inc. is an immunotherapy company focused on the discovery and development of novel therapies that are intended to transform the treatment of cancer. Actym’s STACT technology platform is designed to harness the body’s natural immune system to modify the tumor microenvironment. STACT allows for targeting immune pathways that are intractable using conventional small molecule or antibody-based therapeutics. For more information, please visit: www.actymthera.com.
Sheriese Rush
[email protected]